Stallergenes hunts for U.S. partner

European allergy company Stallergenes is preparing to look for a U.S. partner for its oral hay-fever treatment Oralair. The search will begin in Q4 after the France-based company meets with the FDA. CEO Albert Saporta says Stallergenes has retained Torreya Partners to help with its search and hopes to announce a deal by June 2011. "We are all set to begin our search for a partner," Saporta says, as quoted by Bloomberg. "The kind of partner we are looking for must have a strong sales force in...